Filed Pursuant to Rule 424(b)(2)
Registration No. 333-260578
Prospectus Supplement
(To Prospectus dated October 28, 2021)
$5,500,000,000
Apple Inc.
$1,000,000,000 3.250% Notes due 2029
$1,500,000,000 3.350% Notes due 2032
$1,750,000,000 3.950% Notes due 2052
$1,250,000,000 4.100% Notes due 2062
We are offering $1,000,000,000 of our 3.250% Notes due 2029 (the “2029 Notes”), $1,500,000,000 of our 3.350% Notes due 2032 (the “2032 Notes”), $1,750,000,000 of our 3.950% Notes due 2052 (the “2052 Notes”), and $1,250,000,000 of our 4.100% Notes due 2062 (the “2062 Notes” and, together with the 2029 Notes, the 2032 Notes and the 2052 Notes, the “notes”).
We will pay interest on the 2029 Notes, the 2032 Notes, the 2052 Notes and the 2062 Notes semi-annually in arrears on August 8 and February 8 of each year, beginning on February 8, 2023. The 2029 Notes will mature on August 8, 2029, the 2032 Notes will mature on August 8, 2032, the 2052 Notes will mature on August 8, 2052 and the 2062 Notes will mature on August 8, 2062.
We may redeem the notes in whole or in part at any time or from time to time at the redemption prices described under the heading “Description of the Notes—Optional Redemption” in this prospectus supplement. The notes will be issued only in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.
See “Risk Factors” beginning on page S-6 to read about important factors you should consider before buying the notes.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Public Offering Price(1) | | | Underwriting Discounts | | | Proceeds to Apple, Before Expenses | |
| | Per Note | | | Total | | | Per Note | | | Total | | | Per Note | | | Total | |
2029 Note | | | 99.876 | % | | $ | 998,760,000 | | | | 0.150 | % | | $ | 1,500,000 | | | | 99.726 | % | | $ | 997,260,000 | |
2032 Note | | | 99.882 | % | | $ | 1,498,230,000 | | | | 0.200 | % | | $ | 3,000,000 | | | | 99.682 | % | | $ | 1,495,230,000 | |
2052 Note | | | 99.339 | % | | $ | 1,738,432,500 | | | | 0.400 | % | | $ | 7,000,000 | | | | 98.939 | % | | $ | 1,731,432,500 | |
2062 Note | | | 99.648 | % | | $ | 1,245,600,000 | | | | 0.400 | % | | $ | 5,000,000 | | | | 99.248 | % | | $ | 1,240,600,000 | |
(1) | Plus accrued interest, if any, from August 8, 2022. |
We do not intend to apply for listing of any series of the notes on any securities exchange. Currently, there is no public trading market for any series of the notes.
The underwriters expect to deliver the notes through the book-entry delivery system of The Depository Trust Company and its direct participants, including Clearstream Banking S.A. and Euroclear Bank SA/NV, on or about August 8, 2022, which is the fifth business day following the date of this prospectus supplement. This settlement date may affect trading of the notes. See “Underwriting.”
Joint Book-Running Managers
| | | | | | |
Goldman Sachs & Co. LLC | | BofA Securities | | | J.P. Morgan | |
Barclays | | Deutsche Bank Securities | | | Morgan Stanley | |
Co-Managers
| | | | | | | | |
HSBC | | Academy Securities | | | Cabrera Capital Markets LLC | |
CastleOak Securities, L.P. | | R. Seelaus & Co., LLC | | Ramirez & Co., Inc. | | | Siebert Williams Shank | |
Prospectus Supplement dated August 1, 2022.